BRIEF-M Pharmaceutical agrees to acquire assets from Chelatexx
April 6 (Reuters) - M Pharmaceutical Inc
* Signs definitive agreement to acquire reformulated orlistat for weight loss from Chelatexx LLC
* Says addition of C-103 provides a novel weight loss pharmaceutical product to M Pharma pipeline
* Entered into a definitive agreement to acquire assets from Chelatexx LLC related to a reformulated version of orlistat
* Company also announced it was undertaking a non-brokered private placement of up to $700,000 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
© Thomson Reuters 2017 All rights reserved.